GLAXOSMITHKLINE PHARMACEUTICALS Q3 FY24 Results
GLAXOSMITHKLINE PHARMACEUTICALS has released its financial results for the Q3 quarter of Financial Year 23-2024. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 805.26 Cr
- Quarter-on-Quarter (QoQ) Change: -15.85% (Previous Quarter: Rs. 956.99 Cr )
- Year-on-Year (YoY) Change: 0.37% (Same Quarter Last Year: Rs. 802.30 Cr )
Profitability Metrics
- Net Profit: Rs. 45.72 Cr
- QoQ Profit Change: -78.98% (Previous Quarter: Rs. 217.51 Cr )
- YoY Profit Change: -72.22% (Same Quarter Last Year: Rs. 164.56 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 9.89
- QoQ EPS Change: -22.98% (Previous Quarter: Rs. 12.84)
- YoY EPS Change: 1.85% (Same Quarter Last Year: Rs. 9.71)
Performance Summary
Mixed
GLAXOSMITHKLINE PHARMACEUTICALS had a complex financial situation. Different parts of the business are performing differently, showing a changing market.
This analysis provides a snapshot of GLAXOSMITHKLINE PHARMACEUTICALS's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.